Intermolecular (NASDAQ:IMI) Getting Somewhat Positive News Coverage, Study Finds

News articles about Intermolecular (NASDAQ:IMI) have trended somewhat positive on Tuesday, according to Accern Sentiment. The research group rates the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Intermolecular earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned media coverage about the semiconductor company an impact score of 63 out of 100, meaning that recent media coverage is somewhat likely to have an impact on the stock’s share price in the next few days.

Shares of Intermolecular (IMI) traded down 1.7292% during mid-day trading on Tuesday, hitting $0.9434. The stock had a trading volume of 16,261 shares. The stock’s market cap is $46.75 million. Intermolecular has a 12 month low of $0.78 and a 12 month high of $1.30. The firm has a 50 day moving average price of $0.95 and a 200-day moving average price of $0.95.

Separately, ValuEngine raised Intermolecular from a “strong sell” rating to a “sell” rating in a research note on Monday.

WARNING: This report was first published by BBNS and is the sole property of of BBNS. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://baseballnewssource.com/markets/somewhat-favorable-media-coverage-somewhat-likely-to-impact-intermolecular-nasdaqimi-stock-price-updated-updated-updated/1197058.html.

In related news, major shareholder Lloyd I. Miller III bought 80,000 shares of the company’s stock in a transaction that occurred on Thursday, June 22nd. The stock was bought at an average cost of $0.88 per share, for a total transaction of $70,400.00. Following the acquisition, the insider now directly owns 70,368 shares of the company’s stock, valued at approximately $61,923.84. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have purchased a total of 165,599 shares of company stock valued at $143,226 over the last 90 days. 15.20% of the stock is currently owned by company insiders.

About Intermolecular

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Los Angeles Dodgers Move 50 Games Over .500
Los Angeles Dodgers Move 50 Games Over .500
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Bryce Harper Latest Star to Suffer Injury
Bryce Harper Latest Star to Suffer Injury
Chicago Cubs Must Survive Without Willson Contreras
Chicago Cubs Must Survive Without Willson Contreras


Leave a Reply

 
© 2006-2017 BBNS.